Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
NASDAQ:BRKR

Bruker Q3 2026 Earnings Date & Estimates

Bruker logo
$57.59 +0.28 (+0.49%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$57.58 -0.01 (-0.01%)
As of 10/23/2026 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bruker is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET

What Analysts Expect from Bruker in Q3 2026

Bruker is expected to post earnings of $0.4188 per share on revenue of $865.16 million. In the same quarter a year earlier Bruker reported $0.45 per share on revenue of $860.50 million. Bruker last reported on August 4, 2026, posting $0.49 per share and beating the $0.3849 consensus estimate. Bruker has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.4188
Expected Revenue
$865.16 million
Prior-Year EPS
$0.45
Prior-Year Revenue
$860.50 million
Expected EPS Growth
-6.9%
Expected Revenue Growth
+0.5%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.49 (Beat by +$0.1051)
Last Quarter Revenue
$838.50 million
EPS Beat Rate
5 of last 8 quarters

Bruker Q3 2026 Earnings FAQ

Bruker (NASDAQ:BRKR) has confirmed it will report Q3 2026 earnings on Wednesday, November 4, 2026, before market opens.

Bruker's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Bruker to post earnings of $0.4188 per share for Q3 2026.

The consensus revenue estimate for Bruker is $865.16 million for Q3 2026.

Bruker Earnings Headlines

Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.tc pixel
See More Bruker Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bruker? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bruker and other key companies, straight to your email.

About Bruker

Bruker (NASDAQ:BRKR) develops and manufactures scientific instruments, analytical systems and related software used to study materials, molecules and biological processes. Its technologies support research, discovery and quality control in fields including life sciences, pharmaceutical development, chemical analysis, materials science, environmental testing and clinical research.

The company’s product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, infrared and Raman spectroscopy instruments, X-ray analysis equipment, microscopy and nanoanalysis systems, and preclinical imaging technologies. Bruker also provides software, consumables, technical support and other services that help customers analyze samples and interpret scientific data.

Founded in the 1960s by Günther Laukien, Bruker has grown into an international provider serving academic, government, pharmaceutical, biotechnology, industrial and healthcare customers. The company is headquartered in Billerica, Massachusetts, and operates through a global network of facilities, sales organizations and service teams. Bruker has been led for many years by President and Chief Executive Officer Frank H. Laukien.

View Bruker Profile